Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lunch and Poster Display session

173P - Clinical utility of piezoelectricity hand-held scanner towards breast texture changes and early tumor detection

Date

16 May 2024

Session

Lunch and Poster Display session

Presenters

Joana Gonçalves

Citation

Annals of Oncology (2024) 9 (suppl_4): 1-9. 10.1016/esmoop/esmoop103181

Authors

J.C.N. Gonçalves1, F. Stock2, F. Nogueira2, F. Martins2, I.C. Gomes Fernandes1, R. Gameiro dos Santos1, J. Gramaça1, I.C. Angelo1, C.F.P. Trabulo1, C. Xavier1, I.M. Matos Pina1

Author affiliations

  • 1 Hospital Nossa Senhora do Rosário (Centro Hospitalar Barreiro Montijo, EPE), Barreiro/PT
  • 2 Glooma, Braga/PT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 173P

Background

Breast cancer (BC) is one of the leading causes of cancer death in women worldwide. Screening with mammography (MMG) is limited in low- and middle-income countries. The implementation of affordable and effective screening method is crucial. The Intelligent Breast Exam (iBE) has emerged as portable device with a glove-shaped using piezoelectricity. This study compares the performance of the iBE with MMG or breast magnetic resonance imaging (MRI) and Clinical Breast Examination (CBE).

Methods

The study included patients under surveillance in a Medical Oncology Unit. iBE was performed after each CBE and compared with BI-RADS classifications. MMG/MRI was classified as negative (BI-RADS ≤ 2) or positive (BI-RADS ≥ 3). Measures of accuracy and agreement between tests were calculated.

Results

Between September 2022 to 2023, 151 women were included, who underwent iBE, CBE and MMG/MRI. 48 were excluded due to damaged piezoelectric sensors. There were 29 positive results on CBE and 38 on MMG. 9 women already had a confirmed diagnosis (BI-RADS 6). CBE and MMG showed moderate agreement in categorization (ρ = 0.99). With a specificity for predicting a negative MMG of 90.8% and a negative predictive value of 79.7%. The final diagnosis of all 103 patients was assigned after MMG, CBE and additional biopsy in BIRADS 4 and 5. Benign findings were found in 65 patients, 3 cysts, 6 fibroadenomas, 8 microcalcifications, and 10 BC, excluding the 9 with a previous diagnosis. The performance of IBE was evaluated by comparing the breast with alterations to the control breast within each BI-RADS categorization.

Conclusions

The study aimed to evaluate the IBE performance in comparison with MMG and CBE, concluding that IBE does not detect breast alteration to date. As there is no correlation between iBE and MMG, we are unable to determine the sensitivity and specificity of iBE. Challenges, such as the absence of glove acceleration data, sensor quality, and low sampling rate, hindered iBE effectiveness determination. The improvement proposals emphasized the incorporation of accelerometer sensors, a signal conditioning to allow for the collection of compression and decompression data from the sensors and consideration of pressure stress. These improvements are crucial to optimizing the iBE's ability to detect changes in breast texture, enhancing the iBE's effectiveness in the early detection of BC.

Legal entity responsible for the study

Glooma.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.